Essential Thrombocythemia
Oncology·MeSH: Thrombocythemia, Essential
Prevalence
30.0 / 100K
10 drugs in development·6 companies·7 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Essential Thrombocythemia?
BioSniper tracks 10 drugs in development for Essential Thrombocythemia across 6 companies.
How many clinical trials target Essential Thrombocythemia?
There are 7 clinical trials targeting Essential Thrombocythemia tracked by BioSniper.
What is the prevalence of Essential Thrombocythemia?
The estimated prevalence of Essential Thrombocythemia is approximately 30.0 per 100,000 population.
Deep-dive into Essential Thrombocythemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis